Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Arcutis Biotherapeutics Inc., 3 years.
Arcutis Biotherapeutics Inc.
Director
Vaxcyte Inc.
Director
CytomX Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 14, 2024 | Arcutis Biotherapeutics Inc. | Grant or award | +10,139 | — | — |
| Jun 6, 2024 | Vaxcyte Inc. | Grant or award | +1,550 | — | — |
| Jun 3, 2024 | Vaxcyte Inc. | Option exercise | +18,200 | $5.35 | $97,370 |
| Jun 3, 2024 | Vaxcyte Inc. | Open-market sale | −18,200 | $73.00 | $1,328,600 |
| Jun 13, 2023 | Vaxcyte Inc. | Grant or award | +2,500 | — | — |
| May 31, 2023 | Arcutis Biotherapeutics Inc. | Grant or award | +4,375 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.